Collection's Items (Sorted by Submit Date in Descending order): 361 to 380 of 1011
| Issue Date | Title | Author(s) |
| 2021-03 | Design of Experiment (DoE)-Approach Based RP-HPLC Analytical Method Development and Validation for Estimation of Efavirenz in Bulk and Formulations | Pandey, Murali Monohar |
| 2020-01 | UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery | Pandey, Murali Monohar; Singhvi, Gautam |
| 2021-11 | DoE-based validation of a HPLC–UV method for quantification of rotigotine nanocrystals: Application to in vitro dissolution and ex vivo nasal permeation studies | Pandey, Murali Monohar |
| 2022-01 | Cold atmospheric plasma therapy in wound healing | Pandey, Murali Monohar |
| 2022-03 | Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's | Pandey, Murali Monohar |
| 2022-06 | Emerging trends of nanotechnology in advanced cosmetics | Pandey, Murali Monohar; Singhvi, Gautam |
| 2022-11 | Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review | Pandey, Murali Monohar |
| 2023-01 | Nose-to-brain delivery of rotigotine redispersible nanosuspension: In vitro and in vivo characterization | Pandey, Murali Monohar |
| 2023-05 | Sensitive RP-HPLC method of rivastigmine for applicative quantification of nanostructured lipid carriers | Pandey, Murali Monohar |
| 2023-06 | Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease | Pandey, Murali Monohar |
| 2023-09 | Rivastigmine-DHA ion-pair complex improved loading in hybrid nanoparticles for better amyloid inhibition and nose-to-brain targeting in Alzheimer’s | Pandey, Murali Monohar |
| 2007-06 | In vitro hemolysis and lipid peroxidation-inducing activity of the tentacle extract of the sea anemone (Paracondylactis indicus Dave) in rat erythrocytes | Roy, Aniruddha |
| 2010-09 | Combined Chemo-immunotherapy as a Prospective Strategy To Combat Cancer: A Nanoparticle Based Approach | Roy, Aniruddha |
| 2012-05 | Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of lps for combined chemo-immunotherapy | Roy, Aniruddha |
| 2013-03 | Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model | Roy, Aniruddha |
| 2013-12 | Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles | Roy, Aniruddha |
| 2014-03 | Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxel | Roy, Aniruddha |
| 2014-02 | Carboxymethylcellulose-Based and Docetaxel-Loaded Nanoparticles Circumvent P-Glycoprotein-Mediated Multidrug Resistance | Roy, Aniruddha |
| 2015-08 | Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism | Roy, Aniruddha |
| 2015-06 | A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors | Roy, Aniruddha |
Collection's Items (Sorted by Submit Date in Descending order): 361 to 380 of 1011
